NOVO-B:CPH
Novo Nordisk A/S
DKK 259,60
arrow_downward
-1,46%(-3,85) 1D
16 ຕ.ລ., 17 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVO-B...
Open
DKK 261,00
High
DKK 262,15
Low
DKK 259,35
Mkt. cap
880,08 ຕື້
Avg. vol.
5,23 ລ້ານ
Volume
0,00
52-wk high
DKK 409,95
52-wk low
DKK 224,25
Shares outstanding
3,39 ຕື້
No. of employees
67 ພັນ
Open
DKK 261,00
High
DKK 262,15
Low
DKK 259,35
Mkt. cap
880,08 ຕື້
Avg. vol.
5,23 ລ້ານ
Volume
0,00
52-wk high
DKK 409,95
52-wk low
DKK 224,25
Shares outstanding
3,39 ຕື້
No. of employees
67 ພັນ
News stories
From web sources and news partners
ad-hoc-news.de
·
9 ຊົ່ວໂມງກ່ອນ
Novo-Nordisk stock heads into the next Xetra session at EUR 34.48
The Motley Fool
·
1 ມື້ກ່ອນ
Novo Nordisk and Eli Lilly Just Got Some Fantastic News
Yahoo Finance
·
1 ມື້ກ່ອນ
Novo Nordisk’s Growth Story Is Under Pressure as Eli Lilly Gains Ground
Traders Union
·
1 ມື້ກ່ອນ
Novo Nordisk shares technical analysis: Buyer support underpins upward price move
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
About Novo Nordisk A/S
CEOMaziar Mike Doustdar
Employees66,7 ພັນ
Founded1923
HeadquartersBagsværd, Capital Region of Denmark, ເດນມາກ
SectorPharmaceutical industry
Websitenovonordisk.com